Northwestern University- Lake Forest Hospital

Lake Forest, Illinois 60045

We've found

5 trials

at this facility

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Lake Forest, IL

MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Lake Forest, IL

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Lake Forest, IL

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Lake Forest, IL

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Lake Forest, IL

Use our guide to learn which trials are right for you!